CME Group, the world's leading derivatives marketplace, today reported its Q1 and March 2025 market statistics, with average daily volume (ADV) reaching a new, all-time quarterly record of 29.8 ...

New AI and personalization capabilities extend company’s core CMS offering, delivering a flexible, future-fit solution for brands to create and manage compelling digital experiences Contentful ...

Shares of Biogen Inc. BIIB advanced 5.65% to $120.49 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to 5,456.90 and ...

Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given a consensus rating of “Hold” by the thirty-one brokerages that are ...

Morgan Stanley lowered the firm’s price target on Biogen (BIIB) to $152 from $157 and keeps an Equal Weight rating on the shares. The firm ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...

Biogen ( NASDAQ: BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...

Morgan Stanley (NYSE:MS) analyst Matthew Harrison maintained a Buy rating on Biogen Inc (NASDAQ:BIIB) on Tuesday, setting a... ByInvesting.com • Oct 13, 2020 Orbimed Advisors increased stake in ...

Biogen (NASDAQ:BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense oligonucleotide therapy targeting tau for Alzheimer’s disease treatment. In ...

H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Biogen Inc (NASDAQ:BIIB) on Tuesday, setting a price target of... By Deena Beasley (Reuters) - U.S. health experts this week will ...